{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["COLORECTAL METASTATIC CANCER","CARCINOMA COLON-RETTO METASTATICO","Metastatic colorectal cancer"],"disease":["Metastatic Colorectal Cancer","Carcinoma Colon-retto Metastatico","Colorectal Metastatic Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2535482"],"location":["Italy"],"study_start_month":["7"],"keyword":["proleukin","ENDOXAN"],"repository":["ECRIN MDR"],"study_status":["Ongoing"],"additional_accession":[]},"is_claimable":false,"name":"RESTORE IMMUNE COMPETENCE AGAINST CANCER CELLS IN METASTATIC COLON-RECTAL CARCINOMA RESISTANT TO STANDARD TREATMENTS\nTRANSLATE – Colon-rectal STUDY","description":"Primary objectives: Objective response rate","dates":{"creation":"2016-07-15"},"accession":"2535482","cross_references":{"EU Clinical Trials Register":["2016-000578-39"]}}